Eppendorf introduces the Bioprocess Autosampler, which facilitates sampling 24/7 in short and regular intervals, gaining complete datasets.

Waters Corp introduces its newest MaxPeak Premier Oligonucleotide Columns to support applications for nucleic acid therapeutics and cell and gene therapies.

Gyros Protein Technologies AB has announced the introduction of Gyrolab® Generic Cyno Anti-Drug Antibodies Kit Reagents, for the detection of circulating immune complexes of human IgG with cyno anti-human IgG.

Micronic launches a new addition to its automatic recapping equipment range to accelerate sample storage workflows: the Screw Cap Recapper CS700 with Extended Height.

Agilent Technologies Inc. has announced a strategic partnership with PathAI to deliver biopharmaceutical organizations a solution that combines Agilent’s assay development expertise and PathAI’s algorithm development capabilities.

FUJIFILM Irvine Scientific, Inc. has announced the expansion of its BalanCD CHO Media Platform portfolio with the addition of two new, chemically defined growth media- BalanCD CHO Perfusion and BalanCD CHO DG44.

Cantargia has announced it will host an R&D Day focusing on new clinical results and biomarker data for its lead asset, the IL1RAP-binding antibody nadunolimab, in pancreatic cancer patients.

Evergreen Discovery and Orbit Discovery Ltd have announced that they have entered into a collaboration to identify specific cell targeting peptides and advance the development of novel radiopharmaceuticals.

Thermo Fisher Scientific and Arsenal Biosciences, Inc. have announced an update to their strategic collaboration to further the development of manufacturing processes for new cancer treatments.

 Thermo Fisher Scientific Inc. and the University of California, San Francisco will accelerate advanced cell therapies for difficult-to-treat conditions from a newly opened cGMP manufacturing facility.